{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:16:39Z","timestamp":1790190999823,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">Salmonella typhi<\/jats:italic> and <jats:italic toggle=\"yes\">S. paratyphi<\/jats:italic> are important causes of bacteremia in children, especially those from the developing world. There is a lack of standardized treatment protocols for such patients in the literature, and there are also reports of therapeutic failure related to resistance to commonly used antibiotics. We analyzed the epidemiological, clinical, and antimicrobiological sensitivity patterns of disease in patients diagnosed with blood culture\u2013positive typhoid fever over a 6-month period in a tertiary-care pediatric hospital in western India. Data were retrospectively analyzed for all patients with <jats:italic toggle=\"yes\">Salmonella<\/jats:italic> isolates on blood culture between January 1 and June 30, 2011 at the Synergy Neonatal and Pediatric Hospital. Susceptibility of isolates to antimicrobials and minimum inhibitory concentrations were determined. Demographic data, symptoms and signs, basic laboratory results, treatment courses, and clinical outcomes were collected from clinical charts. All of the 61 isolates of <jats:italic toggle=\"yes\">S. typhi<\/jats:italic> were sensitive to cefepime (fourth-generation cephalosporin), 96% to third-generation cephalosporins, and 95% to quinolones. There was intermediate sensitivity to ampicillin (92%) and chloramphenicol (80%). Notably, azithromycin resistance was observed in 63% of isolates. All patients ultimately made full recoveries. There is an urgent need for large scale, community-based clinical trials to evaluate the effectiveness of different antibiotics in enteric fever. Our antimicrobial susceptibility data suggest that quinolones and third-generation cephalosporins should be used as first-line antimicrobials in enteric fever. Although fourth-generation cephalosporins are useful, we feel their use should be restricted to complicated or resistant cases.<\/jats:p>","DOI":"10.1097\/mjt.0000000000000094","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T11:21:52Z","timestamp":1404300112000},"page":"e1151-e1154","source":"Crossref","is-referenced-by-count":6,"title":["Resistance Patterns of Typhoid Fever in Children: A Longitudinal Community-Based Study"],"prefix":"10.1097","volume":"23","author":[{"given":"Snehal","family":"Vala","sequence":"first","affiliation":[{"name":"Division of Neonatal and Pediatric Emergency Medicine, Synergy Neonatal and Pediatric Hospital, Ahmedabad, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvesh","family":"Shah","sequence":"additional","affiliation":[{"name":"GCS Medical College & Hospital, Ahmedabad, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Amir","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine (Pediatrics), King Khalid University Hospital, College of Medicine and Dentistry, King Saud University, Riyadh, Saudi Arabia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Scolnik","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Emergency Medicine Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Glatstein","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Emergency Medicine Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Ontario, Canada; and"},{"name":"Division of Clinical Pharmacology and Toxicology, Ichilov Hospital, University of Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med."},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1756-0500-6-315","article-title":"Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse","volume":"6","author":"Barrett","year":"2013","journal-title":"BMC Res Notes"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.trstmh.2003.10.014","article-title":"The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam","volume":"98","author":"Parry","year":"2004","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1469-0691.2011.03552.x","article-title":"Treatment of typhoid fever in the 21st century: promises and shortcomings","volume":"17","author":"Butler","year":"2011","journal-title":"Clin Microbiol Infect."},{"issue":"4","key":"R6-20230917","first-page":"CD004530","article-title":"Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)","author":"Thaver","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/JCM.00103-13","article-title":"Neutralization of antimicrobial substances in new BacT\/Alert FA and FN Plus blood culture bottles","volume":"51","author":"Mitteregger","year":"2013","journal-title":"J Clin Microbiol."},{"key":"R10-20230917","first-page":"24","article-title":"Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation","volume":"10","author":"Acharya","year":"2012","journal-title":"Kathmandu Univ Med J (KUMJ)."},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1093\/clinids\/24.Supplement_1.S106","article-title":"Multidrug-resistant Salmonella typhi: a worldwide epidemic","volume":"24","author":"Rowe","year":"1997","journal-title":"Clin Infect Dis."},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00006454-198409000-00017","article-title":"Salmonella strains resistant to multiple antibiotics: therapeutic implications","volume":"3","author":"Smith","year":"1984","journal-title":"Pediatr Infect Dis."},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0035-9203(92)90573-U","article-title":"An outbreak of typhoid due to multidrug resistant Salmonella typhi in Pondicherry","volume":"86","author":"Rao","year":"1992","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"Wain","year":"1997","journal-title":"Clin Infect Dis."},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diagmicrobio.2005.10.016","article-title":"Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003","volume":"54","author":"Shirakawa","year":"2006","journal-title":"Diagn Microbiol Infect Dis."},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(05)75300-9","article-title":"Ciprofloxacin in typhoid fever","volume":"354","author":"Kapil","year":"1999","journal-title":"Lancet"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4269\/ajtmh.2007.76.1174","article-title":"Clonal reconquest of antibiotic-susceptible Salmonella enterica serotype Typhi in Son La Province, Vietnam","volume":"76","author":"Weill","year":"2007","journal-title":"Am J Trop Med Hyg."},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-4453(91)90758-K","article-title":"Modern treatment of typhoid fever","volume":"22","author":"Mandal","year":"1991","journal-title":"J Infect."},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.47.2.827-829.2003","article-title":"Is it time to change fluoroquinolone breakpoints for Salmonella spp.?","volume":"47","author":"Aarestrup","year":"2003","journal-title":"Antimicrob Agents Chemother."}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00045391-201609000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T04:03:19Z","timestamp":1694923399000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201609000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0000000000000094","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}